‘Master protocol’ aims to revamp cancer trials

Pilot project will bring drug companies together to test targeted lung-cancer therapies.

Nature 498 146 doi: 10.1038/498146a

Powered by WPeMatico

Share
This entry was posted in Science. Bookmark the permalink.

Comments are closed.